A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Bhosale, Mayur
- Marburg Haemorrhagic Fever: A Review
Authors
1 Department of Medicinal Chemistry, Pravara Rural College of Pharmacy, Pravaranagar, M.S, IN
2 Department of Pharmaceutical Chemistry, Pravara Rural College of Pharmacy, Pravaranagar A/P- Loni Bk. Taluka -Rahata, Dist-Ahmednagar 413736, (MS), IN
3 Dept of Pharmacology, Pravara Rural College of Pharmacy, Pravaranagar, Loni 413713, IN
Source
Research Journal of Pharmacology and Pharmacodynamics, Vol 1, No 2 (2009), Pagination: 50-55Abstract
Marburg virus belongs to the same virus family, filoviridae, as the virus, which causes Ebola haemorrhagic fever. Marburg virus was first recognized in 1967 when outbreaks of haemorrhagic fever occurred in Marburg and Frankfurt in Germany and in Belgrade in the former Yugoslavia. Multiple organ failure Severe bleeding, Jaundice ,Delirium ,Seizures ,Coma and Shock are common symptoms. Nosocomial transmission via contaminated syringes and needles has been a major problem. Transmission by droplets and small-particle aerosols was observed in outbreaks among experimentally infected (Marburg) and quarantined imported monkeys. Many people were infected as a result of being exposed to African green monkeys imported from Uganda. Secondary spread of the disease is via contact with infected persons or contact with blood, secretions, or excretions of infected persons. The virus may continue to be shed in the patient's semen for up to 3-4 months after illness. One reason the viruses are so deadly is that they interfere with the immune system's ability to mount a defense. ELISA can reveal the correct diagnosis. Till today, no vaccine is available but supportive hospital therapy should be utilized including balancing the patient's fluids and electrolytes, maintaining their oxygen status and blood pressure, replacing lost blood and clotting factors and treating them for any complicating infections.Keywords
Marburg Virus, Haemorrhagic Fever, Filoviruses.References
- Buchan-Osmond, Cornelia. "ICTVdB Virus Description, Marburgvirus". International Committee on Taxonomy of Viruses. 2006, 04-25 Retrieved 2009-02-09.
- CDC Special Pathogens Branch - Known Cases and Outbreaks of Marburg Haemorrhagic Fever, in Chronological Order". Retrieved 2008-03-06.
- World Health Organization workers attacked in angola". Retrieved 2007-05-03.
- Vrouw met Marburg-virus overleden" (in dutch). Retrieved 2008-07-11. Marburg haemorrhagic fever, imported case - United States.
- Feldmann H, Klenk H-D, Sanchez A: Molecular biology and evolution of filoviruses. In Kaaden OR, Eichhorn W, Czerny CP, (eds.): Unconventional Agents and Unclassified Viruses, Arch. Virol. Supplementum, 1993, 7:81.
- Feldmann H, Muhlberger E, Randolf A, et al, Marburg Virus, a filovirus: messenger RNAs, gene order and regulatory elements of the replication cycle. Virus Res. 1992, 24:122-12.
- Feldmann H, Sanchez A, Klenk H-D: Filoviruses. In Topley & Wilson's: Microbiology and Microbial Infections, Edwald Arnold, London, in press, 1998, 45:234-35.
- Martini GA, Siegert R (eds.): Marburg virus disease. New York, Springer Verlag, 1971, 12:114-125.
- Pattyn SR (ed.): Ebola virus haemorrhagic fever. Amsterdam, Elsevier/North- Holland. 1978,08:784-58.
- Peters CJ, Johnson ED, McKee KT: Filoviruses and management of viral haemorrhagic fevers. In Belshe RB (ed.): Textbook of Human Virology, Mosby Year Book, St. Louis; 1991, 159-175.
- Lawrence J, Hill DR. Largest ever Marburg haemorrhagic feveroutbreak, Angola. Eurosurveillance Wkly [Serial online] 2005:10, 14-20.
- Heymann DL. Control of Communicable Diseases Manual.18th edition.Washington: American Public Health Association; 2004.
- WHO. Marburg haemorrhagic fever in Angola - update 15. Available at www.who.int/csr/don/2005_04_22/en/
- WHO. Marburg haemorrhagic fever - fact sheet, 31 March 2005. Available at www.who.int/csr/disease/marburg/factsheet/en/print.html
- Peters CJ, Sanchez A, Feldmann H, Rollin PE, et al: Filoviruses as emerging pathogens. Seminars in Virology, 1994, 5:147.
- Daddario-DiCaprio KM, Geisbert TW, Stroher U, et al. "Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in nonhuman primates: an efficacy assessment". Lancet 367 (9520): 1399-1404.
- Mackenzie, Debora (2007-09-01), "Marburg virus found in fruit bats.", New Scientist (2619): 14, retrieved 2007-09-26
- Peters CJ, Sanchez A, Rollin, PE, et al: Filoviridae: Marburg and Ebola Viruses. In Fields BN, Knipe DM, (eds.): Virology, Raven Press, and New York, in press.
- Sanchez A, Kiley MP, and Holloway BP, Auperin DD: Sequence analysis of the Ebola virus genome: organization, genetic elements and comparison with the genome of Marburg virus. Virus Res. 1993, 29:215.
- Bray and Paragas, 2002: Bray Mike, Paragas Jason Experimental therapy of filovirus infections. Antiviral Research. 2002; 54(1): 1-17.
- Jones SM, Feldmann H, Stroher U et al. "Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses". Nature Med 11, 2005, (7):, 786-90.
- MMWR, 1988: Center for Disease Control and Prevention Management of Patients with Suspected Viral Haemorrhagic Fever. Morb Mortal Weekly Report. 1988; 37(Supplemental 3): 1-16.
- Beer et al, 1999: Beer Brigitte, Kurth Reinhard, Bukreyev Alexander Characteristics of Filoviridae: Marburg and Ebola viruses. Naturwissenschaften. 1999; 86(1): 8-17.
- Rodhain et al, 1989: Rodhain F, Gonzales J. P, Mercier E, Helynck B, Larouze B, Hannoun C. Arbovirus infections and viral haemorrhagic fevers in Uganda: a serological survey in Karamoja district, 1984. Trans R Soc Trop Med Hyg. 1989; 83(6): 851-854.
- Sanchez et al, 2001: Sanchez Anthony, Khan Ali S, Zaki Sherif R, Nabel Gary J, Ksiazek Thomas G, Peters Clarence J. Filorviridae" Marburg and Ebola Viruses. 1279 - 1304. In: Knipe David M, Howley Peter M. Field's Virology Fourth Edition Volume 12001.
- Geisbert and Jaax 1998: Geisbert T.W, Jaax N.K. Marburg haemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy. Ultrastruct Pathol. 1998; 22(1): 3-17.
- Gibb et al, 2001: Gibb T. R, Norwood Jr. D.A, Woollen N, Henchal Development and evaluation of a fluorogenic 5'- nuclease assay to identify Marburg virus. Mol Cell Probes. 2001; 15(5): 259-266.
- Mekki and Van Der Groen, 1981: Mekki A.A, Van Der Groen G. A comparison of indirect immunofluorescence and electron microscopy for the diagnosis of some haemorrhegic viruses in cell cultures. Journal of Virological Methods. 1981; 3(2): 61-69.
- Nakounne et al, 2000: Nakounne E, Selekon B, Morvan J. Microbiological surveillance: viral haemorrhagic fever in Central African Republic: current serological data in man. Bull Soc Pathol Exot. 2000; 93(5): 340-347.
- Saijo et al, 2001: Saijo M, Niikura M, Morikawa S, Ksiazek TG, Meyer RF, Peters CJ, Kurane I. Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. J Clin Microbiol. 2001; 39(1): 1-7.
- Stroher et al, 2001: Stroher Ute, West Elmar, Bugany Harald, Klenk HD, Schnittler HJ, Feldmann H. Infection and Activation of Monocytes by Marburg and Ebola Viruses. Journal of Virology. 2001; 75(22): 11025-11033.
- Vladyko et al, 1991: Vladyko A.S, Chepurnov A.A, Bystrova S.I, Lemeshko NN, Lukashevich IS. The detection of the Marburg virus antigen by solid-phase immunoenzyme analysis. Vopr Virusol. 1991; 36(5): 419-421.
- Marburg Haemorrhagic Fever [ http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/marburg.htm]
- Razumov et al, 2001: Razumov I.A, Belanov E.F, Bormotov N.I, Kazachinskaia EI. Detection of antiviral activity of monoclonal antibodies, specific to Marburg virus proteins. Vopr Virusol. 2001; 46(1): 33-37.
- Geisbert and Jahrling, 1995: Geisbert T.W, Jahrling P.B. Differentiation of filoviruses by electron microscopy. Virus Res. 1995; 39(2-3): 129-150.
- Becker et al, 1992: Becker S, Feldmann H, Will C, Slenczka Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide? Med Microbiol Immunol (Berl). 1992; 181(1): 43-55.
- Alibek,K. and S. Handelman. Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World - Told from Inside by the Man Who Ran it. 1999. Delta (2000) ISBN 0-385-33496-6 Scientists Race to Find Vaccine for Ebola, Marbug -richard knox - NPR. Retrieved on 2007-05-03.}
- http://www.pbs.org/wgbh/nova/bioterror/biow_patrick.html
- Alibek,K. and S. Handelman. Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World - Told from Inside by the Man Who Ran it. 1999. Delta (2000) ISBN 0-385-33496-6.
- Current Scenario of Prescription Writing
Authors
1 PRES College of Pharmacy (D. Pharm), Chincholi- Mohu, Tal-Sinnar, Dist-Nashik, IN
Source
Asian Journal of Pharmacy and Technology, Vol 7, No 3 (2017), Pagination: 144-146Abstract
Prescription writing is one of the difficult tasks performed by the health professionals. A prescription is an instruction from prescriber to a patient as well as pharmacist. Use of proper format for prescription writing ensures appropriate use of drug and helps in minimizing errors. Health professionals must take account of appropriateness, effectiveness, side effects, contraindications and cost when prescribing any medicine. Special care and precautions are needed in prescribing the drugs with abuse potentials to avoid their misuse and to write proper prescription as per format. Every country has its own standards and regulations for prescription writing. This article presents current scenario prescription writing. It may benefit the readers, especially the budding students to ensure the correct format in prescription writing and other relevant aspects.Keywords
Prescription, Components of prescription, prescribing Errors.References
- Medical prescription/Wikipedia, the free encyclopedia.mht
- Davis T. Prescription Writing and the PDR.htm, updated 8/30/2005.
- Donnelley RR. Principles of Prescription Writing and Other Pharmacother-apeutic Considerations, China, June 9, 2008.
- Mercy ships bringing hope and healing. An essential medicines dosing guide based on the WHO model formulary 2008-Prescription writing guidelines.
- Proposed guidelines for prescription writing & handling for drugs having misuse or abuse potential, proposed by FDA, Goa at the stakeholders meeting held on 23rd September, 2009.
- Good practice in prescribing medicines - guidance for doctors.mht, General Medical Council, September 2008.
- Fox A. Safer Prescribing, p1–23. Workbook-Section 1, Prescription writing.
- Benet LZ. Goodman and Gilman’s Principles of Prescription order Writing and Patient Compliance Instructions. The pharmacological basis of therapeutics. In: Gilman AG, Rall TW, Nies AS, Taylor P. 8th ed, vol II, New York: Pergamon press, 1991, 1640–49.
- Lewis VA. Prescription writing and Drug regulation. Pharmacology and Therapeutics for dentistry. In: Yogiela JA, Dowd FJ, Neidle EA. 5th ed., India: Mosby Publishers, 2005, 865–79.
- Dukoff AB. “Did You Know Where Rx Came From?”. Endomail.com. http://www.endomail.com/articles/ad13rx.html. Retrieved 2010-01-22.
- Prescription Writing. Dept. of Pharmacology, GMC Amritsar, p1–19, 14th –17th June 2006.
- Prescription Writing. Dept. of Pharmacology, GMC Amritsar, p1–19, 14th – 17th June 2006.
- Guidelines for Complete, Safe, and Accurate Discharge and Outpatient Prescription Writing, PTNews Virtual Hospital.htm, P&T News: August 2003.
- Torrey T. Why Do Prescription Drug Errors Occur? About.com Guide Updated April, 2010.
- Manchikanti L. National Drug Control Policy and Prescription. Drug Abuse: Facts and Fallacies. Pain Physician 2007; 10:399– 424.
- Teichman PG, Caffee AE. “Prescription writing to maximize patient safety”. Fam Pract Manag 2002; 9:27–30.
- Mikota SK, Plumb DC. Elephant Formulary. Abbreviations Used in Prescription Writing, Published by Elephant Care International - http://www.elephantcare.org, 2003–06.
- University of Florida College of medicine Jacksonville resident Manual. Prescription writing guidelines, reviewed 04/2007.
- Aronson JK. Medication errors: what they are, how they happen, and how to avoid them. QJM 2009; 102, 8:513–52.
- Shtrestha S. Irrational prescription: A hurdle to quality health. The Lancet 2013.
- Kadam A. Rational Drug Use A Concern for Healthcare Professionals. Pharmainfo.net, 2009; 7: 4.
- A Review On: Therapeutic Activities of Spirulinaon Skin
Authors
1 Pravara Rural College of Pharmacy, Pravaranagar, A/P- Loni - 413736, Tal - Rahata, Dist - Ahmednagar, IN
Source
Asian Journal of Pharmaceutical Research, Vol 12, No 3 (2022), Pagination: 235 - 240Abstract
Spirulina stands out as a sustainable bioactive microalga with health- promoting parcels, and an important active element of natural cosmetics products. Presently, Spirulina has been incorporated in topical skin- care phrasings, similar as a moisturizing, antiwrinkles, antiaging and antiacne agent. Likewise, this microalga is used by ornamental inventors to promote healthy sunscreen protection, to treat skin achromatism conditions and to heal injuries. Utmost of marketablecosmetics claim an outsized range of Spirulina parcels, including antioxidant, revitalizing, remineralizing, moisturizing, guarding alongside sanctification and shining action, both for hair and for skin. In this review, recent ornamental operations of Spirulina are revised, by pressing its capability in perfecting skin appearance and health. Also, the analysis of the Spirulina ornamental standardis mooted. Looking at the current emergence of the beauty assiduity, numerous Spirulina extracts anddry cream/ flakes, both the starting element and final Spirulina- rested ornamental products, areavailable on the request. In this artificial field, Spirulina — substantially Spirulina platensis and Spirulinamaxes — is used either as a cream, like in the case of cheaper products, or as a phycocyanin-richblue Extract, particularly in the luxury request.
Keywords
Spirulina platensis, Antioxidant, Anti-acne, Antiwrinkal, Wound healing, BrighteningReferences
- Miranda, M.; Cintra, R.; Barros, S.d.M.; Mancini-Filho, J. Antioxidant activity of the microalga Spirulina maxima. Braz. J. Med.Biol. Res. 1998, 31, 1075–1079.
- Khan, Z.; Bhadouria, P.; Bisen, P. Nutritional and therapeutic potential of Spirulina. Curr. Pharm. Biotechnol. 2005, 6, 373–379.
- Clement, G.; Giddey, C.; Menzi, R. Amino acid composition and nutritive value of the alga Spirulina maxima. J. Sci. Food Agric.1967, 18, 497–501.
- Tomaselli, L. Morphology, ultrastructure and taxonomy of Arthrospira (Spirulina) maxima and Arthrospira (Spirulina) platensis. In Spirulina Platensis (Arthrospira): Physiology, Cell- Biology and Biotechnology; Taylor and Francis: Abingdon, UK, 1997; pp. 1–16.
- Belay, A. Spirulina (Arthrospira): Production and quality assurance. In Spirulina in Human Nutrition and Health; CRC Press: Boca Raton, FL, USA, 2008; Volume 1.
- Babadzhanov, A.; Abdusamatova, N.; Yusupova, F.; Faizullaeva, N.; Mezhlumyan, L.; Malikova, M.K. Chemical Composition of Spirulina platensis Cultivated in Uzbekistan. Chem. Nat. Compd. 2004, 40, 276–279.
- Vonshak, A. Spirulina Platensis Arthrospira: Physiology, Cell- Biology and Biotechnology; CRC Press: Boca Raton, FL, USA, 1997.
- Liestianty, D.; Rodianawati, I.; Arfah, R.A.; Assa, A. Nutritional analysis of spirulina sp to promote as superfood candidate.IOP Conf. Ser. Mater. Sci. Eng. 2019, 509, 012031. [CrossRef]
- Karkos, P.; Leong, S.; Karkos, C.; Sivaji, N.; Assimakopoulos, D. Spirulina in clinical practice: Evidence-based human applications. Evid. Based Complementary Altern. Med. 2011, 2011, 531053.
- Kennedy, D.O. B vitamins and the brain: Mechanisms, dose and efficacy—A review. Nutrients 2016, 8, 68.
- Wells, M.L.; Potin, P.; Craigie, J.S.; Raven, J.A.; Merchant, S.S.; Helliwell, K.E.; Smith, A.G.; Camire, M.E.; Brawley, S.H. Algae asnutritional and functional food sources: Revisiting our understanding. J. Appl. Phycol. 2017, 29, 949–982.
- Makkar, R.; Behl, T.; Bungau, S.; Zengin, G.; Mehta, V.; Kumar, A.; Uddin, M.; Ashraf, G.M.; Abdel-Daim, M.M.; Arora, S. Nutraceuticals in neurological disorders. Int. J. Mol. Sci. 2020, 21, 4424.
- Sorrenti, V.; Fortinguerra, S.; Caudullo, G.; Buriani, A. Deciphering the Role of Polyphenols in Sports Performance: From Nutritional Genomics to the Gut Microbiota toward PhytonutritionalEpigenomics. Nutrients 2020, 12, 1265.
- Sorrenti, V.; Ali, S.; Mancin, L.; Davinelli, S.; Paoli, A.; Scapagnini, G. Cocoa Polyphenols and Gut Microbiota Interplay: Bioavailability, Prebiotic Effect, and Impact on Human Health. Nutrients 2020, 12, 1908.
- Neyrinck, A.M.; Taminiau, B.; Walgrave, H.; Daube, G.; Cani, P.D.; Bindels, L.B.; Delzenne, N.M. Spirulina protects against h
- Hu, J.; Li, Y.; Pakpour, S.; Wang, S.; Pan, Z.; Liu, J.; Wei, Q.; She, J.; Cang, H.; Zhang, R.X. Dose effects of orally administered Spirulina suspension on colonic microbiota in healthy mice. Front. Cell. Infect. Microbiol. 2019, 9, 243.
- Bob Capelli, potential health benefit of spirullinamicroalge, lndependent Consultant.
- Pereira, L. Seaweeds as Source of Bioactive Substances and Skin Care Therapy—Cosmeceuticals, Algotheraphy, and Thalassotherapy. Cosmetics 2018, 5, 68.
- Villaret, A.; Ipinazar, C.; Satar, T.; Gravier, E.; Mias, C.; Questel, E.; Schmitt, A.; Samouillan, V.; Nadal, F.; Josse, G. Raman Characterization of Human Skin Aging. Ski. Res. Technol. 2019, 25, 270–276
- Mourelle, M.L.; Gomez, C.P.; Legido, J.L. The Potential Use of Marine Microalgae and Cyanobacteria in Cosmetics and Thalassotherapy. Cosmetics 2017, 4, 46.
- Lotan, A. Biologic Sunscreen Composition. World Patent No. WO 093388 A2, 12 July 2012.
- Souza, C.; Campos, P.M.B.G.M. Development and Photoprotective Effect of a Sunscreen Containing the Antioxidants Spirulina and Dimethylmethoxy Chromanol on Sun-Induced Skin Damage. Eur. J. Pharm. Sci. 2017, 104, 52–64.
- Souza, C.; de Freitas, L.A.P.; Maia Campos, P.M.B.G. Topical Formulation Containing Beeswax-Based Nanoparticles Improved In Vivo Skin Barrier Function. AAPS Pharm SciTech 2017, 18, 2505–2516.
- Delsin, S.; Mercurio, D.; Fossa, M.; Maia Campos, P. Clinical Efficacy of Dermocosmetic Formulations ContainingSpirulina Extract on Young and Mature Skin: Effects on the Skin Hydrolipidic Barrier and Structural Properties. Clin.Pharmacol. Biopharm. 2015, 4, 1000144–1000149.
- Micali, G.; Innocenzi, D.; Fabbrocini, G.; Monfrecola, G.; Tosti, A.; Veraldi, S. (Eds.) Le Basi Della Dermatologia Anatomica; Springer Press: New York, NY, USA, 2011.
- Panigrahi, B.B.; Panda, P.K.; Patro, V.J. Wound Healing Activity of Spirulina Extracts. Int. J. Pharm. Sci. Rev. Res. 2011,6, 132– 135.
- If Gur, C.S.; Erdogan, D.K.; Onbasılar, I.; Atilla, P.; Cakar, N. In Vitro and in Vivo Investigations of the Wound HealingEffect of Crude Spirulina Extract and C-Phycocyanin. J. Med. Plants Res. 2013, 7, 425–433.
- Gunes, S.; Tamburaci, S.; Dalay, M.C.; Gurhan, I.D. In Vitro Evaluation of Spirulina Platensis Extract Incorporated SkinCream with Its Wound Healing and Antioxidant Activities. Pharm. Biol. 2017, 55, 1824–1832.
- Jung, S.-M.; Min, S.K.; Lee, H.C.; Kwon, Y.S.; Jung, M.H.; Shin, H.S. Spirulina-PCL Nanofiber Wound Dressing to ImproveCutaneous Wound Healing by Enhancing Antioxidative Mechanism. J. Nanomater. 2016, 2016, 613Impro
- Shehadeh, N.H.; Kligman, A.M. The bacteriology of acne. Arch. Dermatol. 1963, 88, 829.
- Kanlayavattanakul, M.; Lourith, N. Therapeutic Agents and Herbs in Topical Application for Acne Treatment. Int. J. Cosmet. Sci. 2011, 33, 289–297.
- Gervason, S.; Metton, I.; Gemrot, E.; Ranouille, E.; Skorski, G.; Cabannes, M.; Berthon, J.; Filaire, E. RhodomyrtusTomentosa Fruit Extract and Skin Microbiota: A Focus on C. Acnes Phylotypes in Acne Subjects. Cosmetics 2020, 7, 53.
- Nihal, B.; Vishal Gupta, N.; Gowda, D.V.; Manohar, M. Formulation and Development of Topical Anti Acne Formulationof Spirulina Extract. Int. J. Appl. Pharm. 2018, 10, 2
- Kumar, V., Bhatnagar, A.K. and Srivastava, J.N. (2011). Antibacterial activity of crude extracts of Spirulina platensis and its structural elucidation of bioactive compound. J Med Plants Res. 5(32): 7043-7048.
- Rajasekar, P., Palanisamy, S., Anjali, R., Vinosha, M., Elakkiya, M., Marudhupandi, T. and Prabhu, N. M. (2019). Isolation and structural characterization of sulfated polysaccharide from Spirulina platensis and its bioactive potential: In vitro antioxidant, antibacterial activity and Zebrafish growth and reproductive performance. International J. of Biological Macromolecules, 141, 809-821.
- Overall Review on Therapeutic effects of Spirulina supplement
Authors
1 Pravara Rural College of Pharmacy, Pravaranagar A/P, Loni - 413736, Tal - Rahata, Dist - Ahmednagar., IN
Source
Research Journal of Science and Technology, Vol 14, No 2 (2022), Pagination: 115-120Abstract
Spirulina play a very important role in human and animal nutrition. Spirulina use as a supermolecule ingredient within the drink,the benefits of spirulina for reducing body fat, spirulina has vital edges for rising blood supermolecule, spirulina promotes immunity boost and energy drink, spirulina use within the preparation of some complementary baby food formulas, spirulina facilitate in maintain sterol level, spirulina protecting impact against polygenic disease.Spirulina stands out as a property bioactive microalga with health-promoting properties, and a very important active ingredient of natural cosmetics merchandise. Currently, Spirulina has beenincorporated in topical skin-care and hair care formulations, such as a moisturizing and Anti-microbial and anti bacteriaagent.References
- W. G. Hopkins and M.R. Wood. “The optimum composition for endurance sports drinks”. Sportscience, 2006, vol. 10, pp. 59-62.
- Anitha L., Chandralekha K., Effect of Supplementation of Spirulina on Blood Glucose, Glycosylated Hemoglobin and Lipid Profile of Male Non-Insulin Dependent Diabetics. Asian JExp. Biol. Sci., 2010, 1(1), 36-46.
- Navacchi M.F.P.; Monteiro de Carvalho J. C.; Takeuchi K. P. and Danesi E.D.G., Development of cassava cake enriched with its own bran and Spirulinaplatensis. Acta Scientiarum Technology (Maringa),2012,34(4),46472,doi:10.4025/actascitechnol.v34i4.10687.
- Dillon JC, Phuc AP, Dubacq JP. Nutritional value of the alga Spirulina. World Rev Nutr Diet 1995; 77: 32-46.
- J.C.DillonandP.A. Phan. “Spirulina as a source of protein in human nutrition”. Bulletin de l’ Institut Océanographique, 1993, vol. 12, pp. 103–107.
- M.Ahsan, B.Habib and M.Parvin. “A review on Culture, Production and Use of Spirulina as Food for Humans and Feeds for Domestic Animals and Fish”.Food and Agriculture Organization of TheUnited Nations, 2008. 33 p. Available at:http://www.fao.org/3/ai0424e.pdf. (accessed 28.04.2019).
- Terry MJ, Maines MD, Lagarias JC. Inactivation of phytochrome and phycobiliprotein-chromophore precursors by rat liver biliverdinreductase. J BiolChem 1993;268:26099–106.
- Strasky Z, Zemankova L, Nemeckova I, et al. Spirulina Platensis and phycocyanobilin activate atheroprotective heme oxygenase-1: a possible implication for atherogenesis. Food Funct2013;4:1586–94.
- Ezzati M, Riboli E. Behavioral and dietary risk factors for noncommunicable diseases. New England Journal of Medicine. 2013;369: 954-964.
- Moradi S, Mirzaei K, Abdurahman AA, Keshavarz SA, Hossein-nezhad A. Mediatory effect of circulating vaspin on resting metabolic rate in obese individuals. European Journal of Nutrition.2016;55(3): 1297-1305.
- Yousefi R, Mottaghi A, Saidpour A. Spirulinaplatensis effectively ameliorates anthropometric measurements and obesity-related metabolic disorders in obese or overweight healthy individuals: a randomized controlled trial. Complementary Therapies in Medicine. 2018;40: 106-112.
- Ramamoorthy A, Premakumari S. Effect of supplementation of Spirulinaon Hypercholesterolemic patients. Journal of Food Science and Technology (Mysore). 1996;33: 124-128.
- Zeinalian R, Farhangi MA, Shariat A, Saghafi-Asl M. The effects of Spirulina platensis onanthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: a randomized double blinded placebo controlled trial. BMC Complementary and Alternative Medicine. 2017;17: 225.
- Hernández-Lepe M, López-Díaz J, Juárez-Oropeza M, Hernández-Torres R, Wall-Medrano A,Ramos-Jiménez A. Effect of Arthrospira (Spirulina) maxima supplementation and a systematic physical exercise program on the body composition and cardiorespiratory fitness of overweight or obese subjects: a double-blind, randomized, and crossover controlled trial. Marine Drugs. 2018;16: E364.
- Brandstrup N, Kirk JE, Bruni C. Determination ofhexokinase in tissues. J Gerontol1957;12:166-171.
- Koida H, Oda T. Pathological occurrence of glucose-6-phosphatase in liver disease. Clin Chim Acta1959;4:554-561.
- Schwartz J,ShklarG. Regression of experimentalhamster cancer bybeta carotene and algae extracts. J Oral Maxillofac Surg. 1987 Jun;45(6): 510–515.
- Ismail MF, Ali DA, Fernando A, et al. Chemoprevention of rat liver toxicity and carcinogenesis by Spirulina. Int J Biol Sci. 2009;5(4):377–387.
- Subhashini J, Mahipal SV, Reddy MC, Mallikarjuna Reddy M,Rachamallu A, Reddanna P. Molecular mechanismsin C-Phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562. BiochemPharmacol. 2004;68(3):453–462.
- Salkic, S.; Ljuca, F.; Batic-Mujanovic, O.; Brkic, S.; Mesic, D.; Mustafic, S. The Frequency of Hypertension Crises in the EmergencyMedical Service Department in Tuzla. Med. Arch. 2013, 67, 393–396.
- Wermelt, J.A.; Schunkert, H. Management der arteriellen Hypertonie. Herz 2017, 42, 515–526.
- Christaki, E.; Florou-Paneri, P.; Bonos, E. Microalgae: A novel ingredient in nutrition. Int. J. Food Sci. Nutr. 2011, 62, 794–799.
- Martínez-Sámano, J.; De Oca, A.T.-M.; Luqueño-Bocardo, O.I.; Torres-Durán, P.V.; Juárez-Oropeza, M.A. Spirulinamaxima Decreases Endothelial Damage and Oxidative Stress Indicators in Patients witSystemic Arterial Hypertension: Results fromExploratory Controlled Clinical Trial. Mar. Drugs 2018, 16, 496.
- Miczke, A.; Szulinska, M.; Hansdorfer-Korzon, R.; Kr˛egielska- Narozna, M.; Suliburska, J.; Walkowiak, J.; Bogda´ nski, P. Effectsofspirulina consumption on body weight, blood pressure, and endothelial function in overweight hypertensive Caucasians: Adouble-blind, placebo-controlled, randomized trial. Eur. Rev. Med. Pharmacol. Sci. 2016, 20, 150–156.
- Lee, E.H.; Park, J.-E.; Choi, Y.-J.; Huh, K.-B.; Kim, W.-Y. A randomized study toestablish the effects of spirulina in type 2 diabetesmellitus patients. Nutr. Res. Pract. 2008, 2, 295–300.
- Serban, M.-C.; Sahebkar, A.; Dragan, S.; Stoichescu-Hogea, G.; Ursoniu, S.; Andrica, F.; Banach, M. A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. Clin. Nutr. 2016, 35, 842–851.
- Bobescu, E.; Bălan, A.; Moga, M.A.; Teodorescu, A.; Mitrică, M.; Dima, L. Are There Any Beneficial Effects of Spirulina Supplementation for Metabolic Syndrome Components in Postmenopausal Women? Mar. Drugs 2020, 18, 651.